Teladoc Health Inc (NYSE:TDOC) shares, rose in value, with the stock price up by 1.68% to the previous day’s close as strong demand from buyers drove the stock to $14.49.
Actively observing the price movement in the last trading, the stock closed the session at $14.25. The value of beta (5-year monthly) was 0.94. Referring to stock’s 52-week performance, its high was $30.41, and the low was $14.05. On the whole, TDOC has fluctuated by -0.62% over the past month.
With the market capitalization of Teladoc Health Inc currently standing at about $2.42 billion, investors are eagerly awaiting this quarter’s results, scheduled for Apr 24, 2024 – Apr 29, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.46, which is expected to increase to -$0.17 for fiscal year -$1.03 and then to about -$0.7 by fiscal year 2025. Data indicates that the EPS growth is expected to be 23.10% in 2025, while the next year’s EPS growth is forecast to be 32.00%.
Analysts have estimated the company’s revenue for the quarter at $637.44 million, with a low estimate of $632.57 million and a high estimate of $645.2 million. According to the average forecast, sales growth in current quarter could jump up 3.10%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $2.67 billion, representing an increase of 2.50% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that TDOC’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of TDOC currently trading nearly -3.72% and -14.78% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 37.49, while the 7-day volatility ratio is showing 4.40% which for the 30-day chart, stands at 3.41%. Furthermore, Teladoc Health Inc (TDOC)’s beta value is 0.95, and its average true range (ATR) is 0.60.
A comparison of Teladoc Health Inc (TDOC) with its peers suggests the former has fared considerably weaker in the market. TDOC showed an intraday change of 1.68% in last session, and over the past year, it shrunk by -44.55%%.
Data on historical trading for Teladoc Health Inc (NYSE:TDOC) indicates that the trading volumes over the past 10 days have averaged 4.16 million and over the past 3 months, they’ve averaged 4.68 million. According to company’s latest data on outstanding shares, there are 166.66 million shares outstanding.
Nearly 1.10% of Teladoc Health Inc’s shares belong to company insiders and institutional investors own 77.39% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 20.28 million shares as on Mar 15, 2024, resulting in a short ratio of 2.87. According to the data, the short interest in Teladoc Health Inc (TDOC) stood at 12.14% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 20.51 million. The stock has fallen by -32.76% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TDOC stock heading into the next quarter.
